PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator

被引:148
作者
Regad, T
Saib, A
Lallemand-Breitenbach, V
Pandolfi, PP
de Thé, H
Chelbi-Alix, MK
机构
[1] Hop St Louis, CNRS, UPR 9051, F-75475 Paris 10, France
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
HFV; Mx; NBs; Tas; transcriptional repression;
D O I
10.1093/emboj/20.13.3495
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The promyelocytic leukaemia (PML) protein localizes in the nucleus both in the nucleoplasm and in matrix-associated multiprotein complexes known as nuclear bodies (NBs), The number and the intensity of PML NBs increase in response to interferon (IFN), Overexpression of PML affects the replication of vesicular stomatitis virus and influenza virus. However, PML has a less powerful antiviral activity against these viruses than the IFN mediator MxA, Here, we show that overexpression of PML, but not that of Mx1 or MxA, leads to a drastic decrease of a complex retrovirus, the human foamy virus (HFV), gene expression. PML represses HFV transcription by complexing the HFV transactivator, Tas, preventing its direct binding to viral DNA. This physical interaction requires the N-terminal region of Tas and the RING finger of PML, but does not necessitate PML localization in NBs, Finally, we show that IFN treatment inhibits HFV replication in wild-type but not in PML-/- cells. These findings point to a role for PML in transcriptional repression and suggest that PML could play a key role in mediating an IFN-induced antiviral state against a complex retrovirus.
引用
收藏
页码:3495 / 3505
页数:11
相关论文
共 57 条
[1]   The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein [J].
Alcalay, M ;
Tomassoni, L ;
Colombo, E ;
Stoldt, S ;
Grignani, F ;
Fagioli, M ;
Szekely, L ;
Helin, K ;
Pelicci, PG .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (02) :1084-1093
[2]   Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein [J].
Chelbi-Alix, MK ;
Quignon, F ;
Pelicano, L ;
Koken, MHM ;
De Thé, H .
JOURNAL OF VIROLOGY, 1998, 72 (02) :1043-1051
[3]   Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins [J].
Chelbi-Alix, MK ;
de Thé, H .
ONCOGENE, 1999, 18 (04) :935-941
[4]  
ChelbiAlix MK, 1995, LEUKEMIA, V9, P2027
[5]  
CHELBIALIX MK, 1996, TUMOR BIOL, V99, P17
[6]  
DANIEL MT, 1993, BLOOD, V82, P1858
[7]   Non-random deletions in human foamy virus long terminal repeat during viral infection [J].
DeCelisKosmas, J ;
Coronel, A ;
Grigorian, I ;
EmanoilRavier, R ;
TobalyTapiero, J .
ARCHIVES OF VIROLOGY, 1997, 142 (06) :1237-1246
[8]   THE PML-RAR-ALPHA FUSION MESSENGER-RNA GENERATED BY THE T(15-17) TRANSLOCATION IN ACUTE PROMYELOCYTIC LEUKEMIA ENCODES A FUNCTIONALLY ALTERED RAR [J].
DETHE, H ;
LAVAU, C ;
MARCHIO, A ;
CHOMIENNE, C ;
DEGOS, L ;
DEJEAN, A .
CELL, 1991, 66 (04) :675-684
[9]  
Duprez E, 1999, J CELL SCI, V112, P381
[10]   A NOVEL MACROMOLECULAR STRUCTURE IS A TARGET OF THE PROMYELOCYTE-RETINOIC ACID RECEPTOR ONCOPROTEIN [J].
DYCK, JA ;
MAUL, GG ;
MILLER, WH ;
CHEN, JD ;
KAKIZUKA, A ;
EVANS, RM .
CELL, 1994, 76 (02) :333-343